Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology

被引:4
|
作者
Qiang, Rui [1 ]
Zhang, Ya [1 ,2 ]
Wang, Yanhong [3 ,4 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing 100053, Peoples R China
[2] Shaanxi Univ Chinese Med, Xianyang 712046, Peoples R China
[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Orthoped, Shanghai 200065, Peoples R China
[4] Minist Educ, Key Lab Spine & Spinal Cord Injury Repair & Regene, Shanghai 200065, Peoples R China
基金
中国国家自然科学基金;
关键词
PROTEIN; 90; INHIBITOR; LIVER FIBROSIS; BETA-SITOSTEROL; STELLATE CELLS; QUERCETIN; PREDICTION; INJURY; INFLAMMATION; PROGRESSION; DOCKING;
D O I
10.1155/2022/8925637
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Purpose. To explore the material basis and pharmacological mechanism of Xiaochaihu Decoction (XCHD), the classic Traditional Chinese Medicine (TCM) formula in inhibiting hepatic fibrosis (HF). Methods. The main components in XCHD were screened from the TCMSP database, ETCM database, and literature, and their potential targets were detected and predicted using the Swiss Target Prediction platform. The HF-related targets were retrieved and screened through GeneCard database and OMIM database, combined with GEO gene chips. The XCHD targets and HF targets were mapped to search common targets. The protein-protein interaction (PPI) network was acquired via the STRING11.0 database and analyzed visually using Cytoscape 3.8.0 software. The potential mechanisms of the common targets identified through GO and KEGG pathway enrichment analysis were analyzed by using Metascape database. The results were visualized through OmicShare Tools. The "XCHD compound-HF target" network was visually constructed by Cytoscape 3.8.0 software. AutoDockVina1.1.2 and PyMoL software were used to verify the molecular docking of XCHD main active compounds and HF key targets. Results. A total of 164 potential active compounds from XCHD were screened to act on 95 HF-related targets. Bioinformatics analysis revealed that quercetin, beta-sitosterol, and kaempferol may be candidate agents, which acted on multiple targets like PTGS2, HSP90AA1, and PTGS1 and regulate multiple key biological pathways like IL-17 signaling pathway, TNF signaling pathway and PI3K-Akt signaling pathway to relieve HF. Moreover, molecular docking suggested that quercetin and PTGS2 could statically bind and interact with each other through amino acid residues val-349, LEU-352, PHE-381, etc. Conclusion. This work provides a systems perspective to study the relationship between Chinese medicines and diseases. The therapeutic efficacy of XCHD on HF was the sum of multitarget and multi-approach effects from the bioactive ingredients. This study could be one of the cornerstones for further research.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking
    Yang, Jing
    Tang, Chaotao
    Jin, Ruiri
    Liu, Bixia
    Wang, Peng
    Chen, Youxiang
    Zeng, Chunyan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction
    Wang, Tianyue
    Jiang, Xinyu
    Ruan, Yanmin
    Zhuang, Jun
    Yin, Yuanjun
    BIOENGINEERED, 2022, 13 (05) : 13767 - 13783
  • [33] Network Pharmacology and In Vivo Analysis of Dahuang-Huangqi Decoction Effectiveness in Alleviating Renal Interstitial Fibrosis
    Luo, Yan
    Xuan, Chen
    Cheng, Junxiong
    Xiong, Yu
    Cao, Wenfu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [34] Network pharmacology, molecular docking and experimental verification reveal the mechanism of Yiguanjian decoction in treating acute liver failure
    Wang, Shuai
    Sun, Yu
    Zhang, Chunmei
    Chen, Bohao
    Zhong, Mei
    Du, Ruili
    Zhou, Yuhang
    Tong, Guangdong
    Luo, Lidan
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2024, 65
  • [35] Transcriptomic analysis reveals pharmacological mechanisms mediating efficacy of Yangyinghuoxue Decoction in CCl4-induced hepatic fibrosis in rats
    Bai, Yanming
    Liang, Shuang
    Zhou, Yanhao
    Zhou, Bo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [36] A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome
    Liu, Lihong
    Du, Bo
    Zhang, Haiying
    Guo, Xiaofei
    Zhou, Zheng
    Xiu, Aihui
    Liu, Chang
    Su, Shiyu
    Ai, Hao
    CHINESE MEDICINE, 2018, 13
  • [37] Network Pharmacology Identifies the Mechanisms of Action of Shaoyao Gancao Decoction in the Treatment of Osteoarthritis
    Zhu, Naiqiang
    Hou, Jingyi
    Ma, Guiyun
    Liu, Jinxin
    MEDICAL SCIENCE MONITOR, 2019, 25 : 6051 - 6073
  • [38] A network pharmacology approach to determine the synergetic mechanisms of herb couple for treating rheumatic arthritis
    Xu, Xi-xi
    Bi, Jian-ping
    Ping, Li
    Li, Ping
    Li, Fei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 967 - 979
  • [39] Identification of the active compounds and significant pathways of yinchenhao decoction based on network pharmacology
    Huang, Jihan
    Cheung, Fan
    Tan, Hor-Yue
    Hong, Ming
    Wang, Ning
    Yang, Juan
    Feng, Yibin
    Zheng, Qingshan
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 4583 - 4592
  • [40] Insights into the molecular mechanisms of Huangqi decoction on liver fibrosis via computational systems pharmacology approaches
    Biting Wang
    Zengrui Wu
    Weihua Li
    Guixia Liu
    Yun Tang
    Chinese Medicine, 16